These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. A proposed mechanism of ADP-ribosylation catalyzed by the pertussis toxin S1 subunit. Locht C, Antoine R. Biochimie; 1995 May 17; 77(5):333-40. PubMed ID: 8527486 [Abstract] [Full Text] [Related]
8. Roles of the disulfide bond and the carboxy-terminal region of the S1 subunit in the assembly and biosynthesis of pertussis toxin. Antoine R, Locht C. Infect Immun; 1990 Jun 17; 58(6):1518-26. PubMed ID: 2341166 [Abstract] [Full Text] [Related]
9. Characterization of pertussis toxin analogs containing mutations in B-oligomer subunits. Loosmore S, Zealey G, Cockle S, Boux H, Chong P, Yacoob R, Klein M. Infect Immun; 1993 Jun 17; 61(6):2316-24. PubMed ID: 8500874 [Abstract] [Full Text] [Related]
11. Structural relationship between the S1 and S4 subunits of pertussis toxin. Sato H, Sato Y. FEMS Microbiol Lett; 1994 Jan 01; 115(1):63-9. PubMed ID: 7510256 [Abstract] [Full Text] [Related]
12. Cloning and sequencing of the pertussis toxin genes: operon structure and gene duplication. Nicosia A, Perugini M, Franzini C, Casagli MC, Borri MG, Antoni G, Almoni M, Neri P, Ratti G, Rappuoli R. Proc Natl Acad Sci U S A; 1986 Jul 01; 83(13):4631-5. PubMed ID: 2873570 [Abstract] [Full Text] [Related]
13. Membrane localization of the S1 subunit of pertussis toxin in Bordetella pertussis and implications for pertussis toxin secretion. Farizo KM, Fiddner S, Cheung AM, Burns DL. Infect Immun; 2002 Mar 01; 70(3):1193-201. PubMed ID: 11854200 [Abstract] [Full Text] [Related]
14. Pertussis holotoxoid formed in vitro with a genetically deactivated S1 subunit. Bartley TD, Whiteley DW, Mar VL, Burns DL, Burnette WN. Proc Natl Acad Sci U S A; 1989 Nov 01; 86(21):8353-7. PubMed ID: 2554311 [Abstract] [Full Text] [Related]
15. A quantitative analysis for the ADP-ribosylation activity of pertussis toxin: an enzymatic-HPLC coupled assay applicable to formulated whole cell and acellular pertussis vaccine products. Cyr T, Menzies AJ, Calver J, Whitehouse LW. Biologicals; 2001 Jun 01; 29(2):81-95. PubMed ID: 11580213 [Abstract] [Full Text] [Related]
16. Importance of holotoxin assembly in Ptl-mediated secretion of pertussis toxin from Bordetella pertussis. Farizo KM, Huang T, Burns DL. Infect Immun; 2000 Jul 01; 68(7):4049-54. PubMed ID: 10858221 [Abstract] [Full Text] [Related]
17. Identification of amino acid residues essential for the enzymatic activities of pertussis toxin. Locht C, Capiau C, Feron C. Proc Natl Acad Sci U S A; 1989 May 01; 86(9):3075-9. PubMed ID: 2470088 [Abstract] [Full Text] [Related]
18. Preliminary X-ray crystallographic analysis of holotoxin from Bordetella pertussis. Raghavan M, Gotto JW, Scott JV, Schutt CE. J Mol Biol; 1990 Jun 05; 213(3):411-4. PubMed ID: 2352276 [Abstract] [Full Text] [Related]
19. Common features of the NAD-binding and catalytic site of ADP-ribosylating toxins. Domenighini M, Magagnoli C, Pizza M, Rappuoli R. Mol Microbiol; 1994 Oct 05; 14(1):41-50. PubMed ID: 7830559 [Abstract] [Full Text] [Related]
20. Subunit S1 of pertussis toxin: mapping of the regions essential for ADP-ribosyltransferase activity. Pizza M, Bartoloni A, Prugnola A, Silvestri S, Rappuoli R. Proc Natl Acad Sci U S A; 1988 Oct 05; 85(20):7521-5. PubMed ID: 2902632 [Abstract] [Full Text] [Related] Page: [Next] [New Search]